LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Sports Medicine/UK Olympian Teams Up With Invibio and CarboFix Orthopedics
Sports Medicine

UK Olympian Teams Up With Invibio and CarboFix Orthopedics

September 13, 2017 2 min read Premium comments

Advertisement

UK Olympian Teams Up With Invibio and CarboFix Orthopedics
United Kingdom’s Olympic Sprinter James Ellington / Courtesy of Invibio and CarboFix Orthopedics
Secondary

United Kingdom’s Olympic Sprinter James Ellington recently teamed up with Invibio Biomaterial Solutions and CarboFix Orthopedics to share how a new fracture treatment has the potential to offer a quicker recovery for patients.

This is a cause close to his heart after a motorcycle accident in Tenerife earlier this year put his athletic ambitions on hold. During a severe head-on collision with a car while on his bike, Ellington’s legs and pelvis were completely smashed.

“My biggest fear was that I would never run again,” he told OTW. “But luckily the surgeon was very conscious of what I do for a living and suggested a CarboFix nail in treating the severe tibia fracture.”

According to Ellington, the CarboFix nail is lighter weight and has a faster healing potential, compared to metal. The rod is made from a new composite polymer from Invibio Biomaterial Solutions, a global leader of PEEK OPTIMA polymer solutions for medical device companies headquartered in the United Kingdom.

“Recovery has been going great. This week I was able to jog on the treadmill and it is going really well. I am hopeful that I will be able to get back on the track.”

John Devine, medical business unit director for Invibio Biomaterial Solutions told OTW that the carbon fiber material from Invibio has a lot of advantages.

“It offers better fatigue resistance than metals for patients who have trouble with healing. Having something that has the potential to last longer can be an advantage but what was really interesting in terms of James and his physician is they wanted it to really accelerate healing.”

“The benefits we hope that it brings is that the implant is less stiff, but at the same time strong enough to treat fracture, and accelerate the healing process.”

Advertisement

According to Matt Cantwell trauma business leader for Invibio Solutions, all people could benefit from the quicker return to function but patients at high risk for a nonunion could be especially good candidates for CarboFix nails or plates. These include patients who have challenges with healing like people suffering from diabetes, obesity or people who have osteoporosis or poor bone quality due to obesity, smoking, and alcohol. High energy fractures like the one that James suffered in his accident also fit into this category.

CarboFix Orthopedics, which is focused on developing orthopedic solutions and is headquartered in Israel, is hoping to help James and other patients with similar injuries recover faster by using trauma implants made from Invibio’s PEEK-OPTIMA Ultra-Reinforced.

Ron Szekely, CarboFix Orthopedics’ vice president of sales and marketing said in a release, “The aim itself to get back on track is fantastic, whether that’s the athletic track or returning to other individual recovery goals. This can be an important driver for rehabilitation.”

“In addition to dedication and enthusiasm, patients need to have access to innovative medical devices that can support this. At CarboFix, we believe in the potential of changing trauma treatments to improve the quality of life for many patients.”

Ellington has already made great progress since his accident and is focused on becoming an active athlete again.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy